Andrew I. Minchinton

7.5k citations

103 papers · 5.1k indexed · 1 hit paper · h-index 30

Co-authors: Ian F. Tannock Alastair H. Kyle Lynsey A. Huxham Jennifer H.E. Baker J. Denekamp M.R.L. Stratford Gerald Krystal Stanley Dische
Topics: Cancer, Hypoxia, and Metabolism (42 papers)Nanoplatforms for cancer theranostics (12 papers)Angiogenesis and VEGF in Cancer (12 papers)
Cited by: Cancer Research Biomaterials Oncology
Journals: Proceedings of the National Academy of Sciences Nature reviews. Cancer Immunity
Partner nations: Canada United Kingdom United States

In The Last Decade

Andrew I. Minchinton

99 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug penetration in solid tumours

2006 2.2k citations Andrew I. Minchinton, Ian F. Tannock Nature reviews. Cancer profile →

Peers

Countries citing papers authored by Andrew I. Minchinton

Since Specialization

Citations

This map shows the geographic impact of Andrew I. Minchinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew I. Minchinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew I. Minchinton more than expected).

Fields of papers citing papers by Andrew I. Minchinton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew I. Minchinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew I. Minchinton. The network helps show where Andrew I. Minchinton may publish in the future.

Co-authorship network of co-authors of Andrew I. Minchinton

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew I. Minchinton. A scholar is included among the top collaborators of Andrew I. Minchinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew I. Minchinton. Andrew I. Minchinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiation and Chemo-Sensitizing Effects of DNA-PK Inhibitors Are Proportional in Tumors and Normal Tissues 2024 ·Molecular Cancer Therapeutics ·Jennifer H.E. Baker,Alastair H. Kyle,(unknown),(unknown),Xinhe Liu,(unknown),Judit P. Banáth,Andrew I. Minchinton	4
2	Radiosensitizing oxygenation changes in murine tumors treated with VEGF-ablation therapy are measurable using oxygen enhanced-MRI (OE-MRI) 2023 ·Radiotherapy and Oncology ·Jennifer H.E. Baker,(unknown),Alastair H. Kyle,Judit P. Banáth,Katayoun Saatchi,Urs O. Häfeli,Stefan A. Reinsberg,Andrew I. Minchinton	1
3	Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically 2019 ·Cancer Immunology Research ·Shawn C. Chafe,Paul C. McDonald,Saeed Saberi,Oksana Nemirovsky,Geetha Venkateswaran,Samantha Burugu,Dongxia Gao,Alberto Delaidelli,Alastair H. Kyle,Jennifer H.E. Baker,Jordan Gillespie,Ali Bashashati,Andrew I. Minchinton,Youwen Zhou,Sohrab P. Shah,Shoukat Dedhar	126
4	Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment 2018 ·Clinical & Experimental Metastasis ·Jennifer H.E. Baker,Alastair H. Kyle,Stefan A. Reinsberg,(unknown),(unknown),(unknown),Katayoun Saatchi,Urs O. Häfeli,Andrew I. Minchinton	41
5	Endothelial-Specific Notch Blockade Inhibits Vascular Function and Tumor Growth through an eNOS-Dependent Mechanism 2014 ·Cancer Research ·Alexandre Patenaude,Megan Fuller,Linda Chang,Fred Wong,Grigorios Paliouras,(unknown),Alastair H. Kyle,(unknown),Jennifer H.E. Baker,(unknown),(unknown),Andrew I. Minchinton,Aly Karsan	29
6	Tissue Penetration and Activity of Camptothecins in Solid Tumor Xenografts 2014 ·Molecular Cancer Therapeutics ·Alastair H. Kyle,Jennifer H.E. Baker,(unknown),Stefan A. Reinsberg,Andrew I. Minchinton	16
7	Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition 2012 ·Cancer Research ·Christopher Daly,Alexandra Eichten,Carla Castanaro,Elizabeth Pasnikowski,Alexander P. Adler,Alshad S. Lalani,Nicholas Papadopoulos,Alastair H. Kyle,Andrew I. Minchinton,George D. Yancopoulos,Gavin Thurston	180
8	Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling 2012 ·Proceedings of the National Academy of Sciences ·Linda Chang,Michela Noseda,Michelle Higginson,Michelle Ly,Alexandre Patenaude,Megan Fuller,Alastair H. Kyle,Andrew I. Minchinton,Mira C. Puri,Daniel Dumont,Aly Karsan	61
9	Targeting Quiescent Tumor Cells via Oxygen and IGF-I Supplementation 2011 ·Cancer Research ·Alastair H. Kyle,Jennifer H.E. Baker,Andrew I. Minchinton	29
10	A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation 2011 ·Cancer Research ·Victor W. Ho,Kelvin K. Leung,(unknown),(unknown),(unknown),(unknown),Andrew I. Minchinton,Dawn Waterhouse,Marcel B. Bally,(unknown),Brad H. Nelson,Laura M. Sly,Gerald Krystal	103
11	In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer 2011 ·Clinical Cancer Research ·Clement Mugabe,Yoshiyuki Matsui,Alan So,Martin Gleave,Jennifer H.E. Baker,Andrew I. Minchinton,(unknown),Richard Liggins,Donald E. Brooks,Helen M. Burt	51
12	Notch Initiates the Endothelial-to-Mesenchymal Transition in the Atrioventricular Canal through Autocrine Activation of Soluble Guanylyl Cyclase 2011 ·Developmental Cell ·Alex Chia Yu Chang,Yang‐Xin Fu,Victoria C. Garside,Kyle Niessen,Linda Chang,Megan Fuller,Audi Setiadi,(unknown),Alastair H. Kyle,Andrew I. Minchinton,Marco A. Marra,Pamela A. Hoodless,Aly Karsan	134
13	Classification of anticancer drugs based on tissue penetration using a novel in vitro screening assay 2007 ·Molecular Cancer Therapeutics ·Alastair H. Kyle,Andrew I. Minchinton	1
14	Drug penetration in solid tumoursbreakdown → 2006 ·Nature reviews. Cancer ·Andrew I. Minchinton,Ian F. Tannock	2213
15	Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts 2006 ·Radiotherapy and Oncology ·Lynsey A. Huxham,Alastair H. Kyle,Jennifer H.E. Baker,(unknown),Andrew I. Minchinton	15
16	HER-2/neuOverexpression Increases the Viable Hypoxic Cell Population within Solid Tumors without Causing Changes in Tumor Vascularization 2004 ·Molecular Cancer Research ·Wieslawa H. Dragowska,Corinna Warburton,Donald T. Yapp,Andrew I. Minchinton,Yanping Hu,Dawn Waterhouse,Karen A. Gelmon,Kirsten A. Skov,Janet Woo,Dana Masin,Lynsey A. Huxham,Alastair H. Kyle,Marcel B. Bally	23
17	Characterization of Three-Dimensional Tissue Cultures Using Electrical Impedance Spectroscopy 1999 ·Biophysical Journal ·Alastair H. Kyle,(unknown),Andrew I. Minchinton	74
18	Effect of Breathing Carbogen on the Oxygen Tension Of Murine and Human Tumours Measured Using an Eppendorf pO2 Histograph 1999 ·Advances in experimental medicine and biology ·Andrew I. Minchinton,(unknown),Peter Lim,Christina Aquino‐Parsons	3
19	Measurements of glutathione and other thiols in cells and tissues: A simplified procedure based on the HPLC separation of monobromobimane derivatives of thiols 1984 ·International Journal of Radiation OncologyBiologyPhysics ·Andrew I. Minchinton	28
20	Importance of ph induced concentration gradients in the use of nitro imidazole radio sensitizers with basic and acidic substituents 1982 ·British Journal of Radiology ·Eric D. Clarke,M.F. Dennis,(unknown),Andrew I. Minchinton,M.R.L. Stratford,Peter Wardman,M.E. Watts	3

About Andrew I. Minchinton

Andrew I. Minchinton is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 103 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (42 papers), Nanoplatforms for cancer theranostics (12 papers) and Angiogenesis and VEGF in Cancer (12 papers). The work is most often cited by research in Cancer Research (1.1k citations), Biomaterials (824 citations) and Oncology (1.4k citations). Andrew I. Minchinton has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Ian F. Tannock, Alastair H. Kyle, Lynsey A. Huxham, Jennifer H.E. Baker, J. Denekamp, M.R.L. Stratford, Gerald Krystal, Stanley Dische, Victor W. Ho and Laura M. Sly. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature reviews. Cancer and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact